EXAS+123.64%12.9%
NTRA+98.81%11.5%
GH+265.96%10.0%
NEO+186.52%8.5%
QGEN-11.69%7.2%
TEM-15.90%6.5%
VACY—6.5%
CSTL+53.85%5.7%
GRAL+124.24%5.7%
LH+20.36%5.0%
ABT-18.53%4.4%
ILMN+111.66%4.3%
MYGN-44.44%4.3%
DGX+36.32%4.2%
PSNL+206.92%2.2%
BDX+27.28%1.0%
As of Aug 6, 2026, 4:25 AM ET
MedTech Long '26: Diagnostics & Early Detection Constituents
Exact Sciences CorporationEXAS | 12.9% | 0.00% | 0.00% | 0.00% | 0.00% | 3.30% | 1.48% | 135.44% | 123.64% | $20.03B |
Natera, Inc.NTRA | 11.5% | -0.21% | 4.82% | -3.23% | 2.56% | 19.87% | 32.00% | 91.77% | 98.81% | $39.33B |
Guardant Health, Inc.GH | 10.0% | 2.12% | 10.76% | -3.34% | 0.73% | 59.76% | 73.78% | 275.21% | 265.96% | $21.90B |
NeoGenomics, Inc.NEO | 8.5% | -3.44% | 13.25% | 3.76% | 2.88% | 33.76% | 60.02% | 66.99% | 186.52% | $409.6M |
Qiagen N.V.QGEN | 7.2% | -0.92% | 1.38% | 13.78% | 1.30% | -6.74% | -15.78% | 4.80% | -11.69% | $8.65B |
Tempus AI, Inc.TEM | 6.5% | -0.74% | 9.39% | -23.06% | 6.45% | -20.91% | -12.30% | -6.39% | -15.90% | $8.18B |
—VACY | 6.5% | — | — | — | — | — | — | — | — | — |
Castle Biosciences, Inc.CSTL | 5.7% | -2.50% | 23.15% | 25.57% | 8.57% | -21.85% | 2.81% | 50.57% | 53.85% | $922.0M |
GRAIL Inc.GRAL | 5.7% | 2.04% | 9.35% | 7.59% | 8.20% | -13.33% | 39.36% | 183.78% | 124.24% | $3.18B |
Labcorp Holdings Inc.LH | 5.0% | 0.52% | 5.79% | 10.40% | 1.54% | 25.14% | 8.59% | 32.83% | 20.36% | $25.74B |
Abbott LaboratoriesABT | 4.4% | 0.19% | 2.52% | 10.49% | -0.04% | -15.24% | -9.19% | -18.41% | -18.53% | $184.13B |
Illumina, Inc.ILMN | 4.3% | -1.55% | 2.98% | 2.85% | -2.55% | 52.39% | 48.65% | 144.10% | 111.66% | $30.24B |
Myriad Genetics, Inc.MYGN | 4.3% | -0.63% | -43.85% | -47.76% | 10.14% | -48.78% | -31.67% | -64.20% | -44.44% | $297.5M |
Quest Diagnostics IncorporatedDGX | 4.2% | 0.91% | 3.50% | 10.94% | 1.21% | 35.91% | 11.29% | 41.10% | 36.32% | $26.03B |
Personalis, Inc.PSNL | 2.2% | 0.00% | 14.77% | -5.72% | 6.79% | 69.85% | 49.23% | 279.78% | 206.92% | $1.44B |
Becton, Dickinson and CompanyBDX | 1.0% | 0.32% | 9.15% | 9.72% | 3.04% | 11.86% | -3.30% | -2.49% | 27.28% | $47.02B |
| Theme return | — | -0.28% | 4.85% | -0.20% | 2.30% | 15.05% | 20.71% | 96.81% | 88.52% | — |
| Average | 6.2% | -0.26% | 4.46% | 0.80% | 3.39% | 12.33% | 17.00% | 80.99% | 77.67% | $27.83B |
| Median | 5.7% | 0.00% | 5.79% | 3.76% | 2.56% | 11.86% | 8.59% | 50.57% | 53.85% | $20.03B |
| Std Dev | 3.1% | 1.44% | 14.18% | 16.76% | 3.61% | 32.94% | 30.32% | 100.42% | 89.03% | $44.22B |
| Min | 1.0% | -3.44% | -43.85% | -47.76% | -2.55% | -48.78% | -31.67% | -64.20% | -44.44% | $297.5M |
| Max | 12.9% | 2.12% | 23.15% | 25.57% | 10.14% | 69.85% | 73.78% | 279.78% | 265.96% | $184.13B |
| % Positive Tickers | 40.00% | 86.67% | 60.00% | 80.00% | 60.00% | 66.67% | 73.33% | 73.33% |
About this theme
MedTech Long '26: Diagnostics & Early Detection tracks 16 publicly listed stocks in this theme. Sample tickers: ABT, BDX, CSTL, DGX, EXAS, GH, GRAL, ILMN, LH, MYGN, NEO, NTRA, and 4 more. Use the table below for the full list.
